Bcli stock price today
Brainstorm Cell Therapeutics Inc. Common Stock (BCLI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. View the latest Brainstorm Cell Therapeutics Inc. (BCLI) stock price, news, historical charts, analyst ratings and financial information from WSJ. Stock analysis for BrainStorm Cell Therapeutics Inc (BCLI:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and Stock Price Forecast for BCLI: Brainstorm Cell Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple
Stock Price Forecast for BCLI: Brainstorm Cell Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple
In addition, this page includes various stock data for Brainstorm Cell Therapeutics, such as the latest Brainstorm Cell Therapeutics stock price history, total returns, stock price today in addition to fundamental data such as earnings and dividends as well as … BCLI - Stock quote for BRAINSTORM CELL THERAPEUTICS INC ... View the latest BCLI stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of BRAINSTORM CELL THERAPEUTICS INC.. BCLI Stock News - Fidelity Apr 02, 2020 · International Pharmaceutical Veteran to Lead Global Business and Commercial Development Ralph Kern, MD, MHSc, Promoted to President BrainStorm Cell Therapeutics, Inc. (BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced that David Setboun, Pharm.D., MBA, has been appointed Executive Vice President and Chief Operating Officer. Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) price ... Sep 13, 2018 · Today, Maxim Group set its price target on Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) to $9.00 per share. There are 2 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on
BCLI | Stock Snapshot - Fidelity
Get breaking news and analysis on Brainstorm Cell Therapeutics Inc. (BCLI) stock, price quote and chart, trading and investing tools.
Brainstorm Cell Therapeutics Inc. Common Stock (BCLI ...
Oct 28, 2019 · 1 Wall Street analysts have issued ratings and price targets for Brainstorm Cell Therapeutics in the last 12 months. Their average twelve-month price target is $9.00, suggesting that the stock has a possible upside of 103.62%. The high price target for BCLI is $9.00 and the low price target for BCLI is $9.00. BCLI | Stock Snapshot - Fidelity Apr 02, 2020 · Stock quote and company snapshot for BRAINSTORM CELL THERAPEUTICS INC (BCLI), including profile, stock chart, recent news and events, analyst opinions, and research reports. Brainstorm Cell Therapeutics Inc. Common Stock (BCLI) Real ... Brainstorm Cell Therapeutics Inc. Common Stock (BCLI) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. BCLI - Brainstorm Cell Stock Price History - Barchart.com The historical data and Price History for Brainstorm Cell (BCLI) with Intraday, Daily, Weekly, Monthly, and Quarterly data available for download. Today's Top Stock Pick All Top Stock Picks. Performance Leaders. Percent Change Price Change Range Change Gap Up & Gap Down Five Day Gainers.
Brainstorm Cell Therapeutics Inc. - TheStreet
Brainstorm Cell Therapeutics (BCLI) has the following price history information. Looking back at BCLI historical stock prices for the last five trading days, on March 26, 2020, BCLI opened at $4.88, traded as high as $5.25 and as low as $4.88, and closed at $4.90. Trading volume was a total of 403.10K shares. Brainstorm Cell Therapeutics Inc : BCLI Stock Price Quote ... Free current stock price quotes and data for Brainstorm Cell Therapeutics Inc (BCLI). Research news, charts, stock market performance and earnings.
See Brainstorm Cell Therapeutics Inc. (BCLI) history of stock splits. Includes date and ratio. Stock Movers: Why Brainstorm Cell Therapeutics Inc. (BCLI ... Mar 17, 2020 · This means the stock has a potential increase of 120.31% from where the BCLI share price has been trading recently. During the recent trading session for Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI), the company witnessed their stock drop by $-2.46 over a week and tumble down $-1.35 from the price 20 days ago. BCLI Brainstorm Cell Therapeutics Inc. Stock Quote Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of central nervous system (CNS) adult stem cell therapies designed to address the unmet medical needs of patients with debilitating neurodegenerative diseases. BCLI Historical Stock Prices Brainstorm Cell Therapeutics (BCLI) has the following price history information. Looking back at BCLI historical stock prices for the last five trading days, on March 26, 2020, BCLI opened at $4.88, traded as high as $5.25 and as low as $4.88, and closed at $4.90. Trading volume was a total of 403.10K shares.